These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 395139)
1. The effect of BCNU combined with total body irradiation or cyclophosphamide on survival of dogs after autologous marrow grafts. Paterson AH; English D Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1585-7. PubMed ID: 395139 [No Abstract] [Full Text] [Related]
2. Combination of high-dose cyclophosphamide, BCNU, and VP-16-213 followed by autologous marrow rescue in the treatment of relapsed leukemia. Zander AR; Vellekoop L; Spitzer G; Verma DS; Litam J; McCredie KB; Keating M; Hester JP; Dicke KA Cancer Treat Rep; 1981; 65(5-6):377-81. PubMed ID: 7016323 [TBL] [Abstract][Full Text] [Related]
3. Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation. Johnson DB; Thompson JM; Corwin JA; Mosley KR; Smith MT; de los Reyes RA; Daly MB; Petty AM; Lamaster D; Pierson WP J Clin Oncol; 1987 May; 5(5):783-9. PubMed ID: 3553437 [TBL] [Abstract][Full Text] [Related]
6. High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity. van Besien K; Tabocoff J; Rodriguez M; Andersson B; Mehra R; Przepiorka D; Dimopoulos M; Giralt S; Suki S; Khouri I Bone Marrow Transplant; 1995 Apr; 15(4):549-55. PubMed ID: 7655380 [TBL] [Abstract][Full Text] [Related]
7. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies. Wu DP; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp MJ; Bourdin S; Mahe JM; Harousseau JL Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008 [TBL] [Abstract][Full Text] [Related]
8. Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease. Reece DE; Barnett MJ; Connors JM; Fairey RN; Fay JW; Greer JP; Herzig GP; Herzig RH; Klingemann HG; LeMaistre CF J Clin Oncol; 1991 Oct; 9(10):1871-9. PubMed ID: 1919637 [TBL] [Abstract][Full Text] [Related]